Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective

被引:18
作者
Miller, Grover P. [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
关键词
CYP2E1; cytochrome P450; in vitro; kinetic profiling; metabolism; modeling; mutagenesis; quantitative structure-activity relationship; xenobiotic;
D O I
10.1517/17425255.4.8.1053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Background: Cytochrome P450 2E1 (CYP2E1) plays a central role in the metabolism and metabolic activation of a large number of small, mostly xenobiotic compounds. These qualities distinguish CYP2E1 from traditional enzymes and pose significant challenges to understanding the role and consequences of CYP2E1-mediated metabolism. Objective: This review discusses recent advances in kinetic profiling, quantitative structure-activity relationships and structural studies that have furthered the development of tools to interpret and predict CYP2E1 metabolism. Methods: Analysis of kinetic profiles by specific mechanisms produces important parameters describing specificity, stoichiometry and metabolism of molecules. Quantitative structure-activity relationships reveal a more specific basis for molecular recognition by CYP2E1. The corresponding protein structures imparting these interactions are the focus of chemical modifications, site-directed mutagenesis and homology modeling studies. Results: Compilation of kinetic profiling for CYP2E1 substrates established the selectivity for small substrates, whose characteristics could be generalized in parameters for hydrophobicity and steric properties as determined by quantitative structure-activity relationships. The possibility of an effector site for monocyclic compounds added an interesting variable to these modeling efforts. Various structural studies identified important residues contributing to binding and catalysis as well as the volume and location of the active site relative to the heme moiety. Pressure and carbon monoxide-binding experiments also demonstrated the inherent conformational flexibility of CYP2E1 that may contribute to rate-limiting steps during catalytic turnover. Conclusion: Although combinations of these approaches have reinforced important observations, more work is needed to verify findings and seek broader impacts for various interpretative and predictive tools.
引用
收藏
页码:1053 / 1064
页数:12
相关论文
共 58 条
[1]
Active sites of two orthologous cytochromes P450 2E1: Differences revealed by spectroscopic methods [J].
Anzenbacherova, E ;
Hudecek, J ;
Murgida, D ;
Hildebrandt, P ;
Marchal, S ;
Lange, R ;
Anzenbacher, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (01) :477-482
[2]
Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions [J].
Atkins, WM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :291-310
[3]
A unified theory of enzyme kinetics based upon the systematic analysis of the variations of kcat, and KM, and kcat/KM and the relevant ΔG0≠ values -: possible implications in chemotherapy and biotechnology [J].
Bauer, C ;
Osman, AM ;
Cercignani, G ;
Gialluca, N ;
Paolini, M .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (09) :1049-1055
[4]
Oxidation kinetics of ethanol by human cytochrome P450 2E1 - Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b(5) on steady-state kinetics [J].
Bell, LC ;
Guengerich, FP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (47) :29643-29651
[5]
Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes [J].
Bellec, G ;
Dreano, Y ;
Lozach, P ;
Menez, JF ;
Berthou, F .
CARCINOGENESIS, 1996, 17 (09) :2029-2034
[6]
Novel reversible inactivation of cytochrome P450 2E1 T303A by tert-butyl acetylene:: The role of threonine 303 in proton delivery to the active site of cytochrome P450 2E1 [J].
Blobaum, AL ;
Kent, UM ;
Alworth, WL ;
Hollenberg, PF .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01) :281-290
[7]
Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes:: Characterization of reactive intermediate adducts to the heme and apoprotein [J].
Blobaum, AL ;
Kent, UM ;
Alworth, WL ;
Hollenberg, PF .
CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (12) :1561-1571
[8]
Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation [J].
Born, SL ;
Caudill, D ;
Fliter, KL ;
Purdon, MP .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (05) :483-487
[9]
BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125
[10]
Oxidative stress, toxicology, and pharmacology of CYP2E1 [J].
Caro, AA ;
Cederbaum, AI .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :27-42